Allarity TherapeuticsALLR
13F holders, Q2 2025 (June 30)10holders +1
4new positions
3sold out
$1.01avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Allarity Therapeutics Inc. (ALLR) in their 13F filings, up 1 from Q1 2025. 4 opened new positions and 3 sold out. The largest holders were XTX Topco Ltd ($51K), Geode Capital Management, LLC ($51K) and UBS Group AG ($48K).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $94K |
| Exits | 3 | $50K |
All 13F filers, Q1 2025 → Q2 2025: 157,750 shares bought and 55,021 shares sold, net +102,729 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| XTX Topco Ltd | 0.00% | New | 50,950 | $51K |
| Geode Capital Management, LLC | 0.00% | Add +49.3% | 50,650 | $51K |
| UBS Group AG | 0.00% | Add +15894.7% | 47,984 | $48K |
| Jane Street Group, LLC | 0.00% | New | 26,365 | $27K |
| Squarepoint Ops LLC | 0.00% | New | 14,450 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -34.7% | 3,073 | $3K |
| Citigroup Inc. | 0.00% | New | 1,472 | $1K |
| Bank of America Corp. | 0.00% | Add +263.2% | 138 | $139 |
| Osaic Holdings, Inc. | 0.00% | No change | 7 | $7 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ALLR's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.